Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank71
3Y CAGR+95.7%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+95.7%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
7.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.49M+1267.1%
2024$182422.00-92.7%
2023$2.49M+646.6%
2022$332919.00+138.8%
2021$-857833.00+44.9%
2020$-1.56M+66.4%
2019$-4.64M+43.3%
2018$-8.19M-622.1%
2017$-1.13M-197.1%
2016$1.17M-